Capricor Therapeutics Inc (CAPR)
6.306
+0.01
(+0.10%)
USD |
NASDAQ |
May 21, 16:00
6.306
0.00 (0.00%)
After-Hours: 18:37
Capricor Therapeutics Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.223M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 4.835M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | 1.264M |
| June 30, 2017 | 2.177M |
| March 31, 2017 | 2.506M |
| December 31, 2016 | 3.039M |
| September 30, 2016 | 3.920M |
| June 30, 2016 | 2.924M |
| March 31, 2016 | 3.224M |
| December 31, 2015 | 2.530M |
| September 30, 2015 | 2.309M |
| June 30, 2015 | 2.679M |
| March 31, 2015 | 2.746M |
| December 31, 2014 | 1.699M |
| September 30, 2014 | 1.613M |
| June 30, 2014 | 1.683M |
| March 31, 2014 | 1.519M |
| December 31, 2013 | 1.629M |
| September 30, 2013 | 0.3392M |
| June 30, 2013 | 0.3976M |
| March 31, 2013 | 0.2494M |
| December 31, 2012 | 0.2647M |
| September 30, 2012 | 0.21M |
| June 30, 2012 | 0.1217M |
| March 31, 2012 | 0.3272M |
| December 31, 2011 | 0.4378M |
| September 30, 2011 | 0.5043M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.835M
Minimum
Dec 2022
6.223M
Maximum
Dec 2023
5.529M
Average
5.529M
Median
Accounts Payable (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 91.54M |
| PTC Therapeutics Inc | 27.46M |
| Solid Biosciences Inc | 1.73M |
| Inovio Pharmaceuticals Inc | 8.297M |
| Stereotaxis Inc | 3.307M |